ArticleInternational journal of clinical oncology2010

Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer: retrospective analysis.

Takeshi Sakamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.